Sex‐related differences in hospital admissions attributed to adverse drug reactions in the Netherlands
Open Access
- 27 September 2010
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 71 (1) , 95-104
Abstract
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECTWomen are more at risk for developing adverse drug reactions (ADRs) due to differences in pharmacokinetics, pharmacodynamics and drug use. ADRs regularly lead to hospital admissions.WHAT THIS STUDY ADDSThere are differences between the sexes in hospital admissions attributed to ADRs. The risk of being hospitalized with an ADR varies between the sexes in the type of reaction and the causative drug.AIMAdverse drug reactions (ADRs) are a major burden in health care, regularly leading to hospital admission, morbidity or death. Women tend to have a higher risk of adverse drug reactions with a 1.5 to 1.7‐fold greater risk than men. Our primary aim was to study differences in ADR‐related hospitalizations between the sexes.METHODSWe conducted a nationwide study of all ADR‐related hospitalizations in the period between 2000 and 2005 in the Netherlands, which were selected from all 9 287 162 hospital admissions in this period. ADR–drug group combinations with at least 50 admissions in one of the sexes were selected. Relative risks and confidence intervals were calculated with respect to total admissions and total prescriptions with men as reference.RESULTSIn total, 0.41% of the 4 236 368 admissions in men (95% CI 0.40, 0.42%) and 0.47% of the 5 050 794 admissions in women (95% CI 0.46, 0.48%) were attributed to an ADR by medical specialists (57% of all ADR‐related admissions were in women). Differences between the sexes in risk for ADR‐related hospitalization were found for antineoplastic and immunosuppressive drugs, antirheumatics, anticoagulants and salicylates, cardiovascular and neurological drugs, steroids and antibiotics. In certain drug categories, risks for hospitalization changed after taking into account total drug prescriptions.CONCLUSIONIn all different drug classes, significant differences exist between the sexes in ADR‐related hospital admissions. Cardiovascular drugs account for the most pronounced differences between men and women. More research is needed to explain the clear sex differences in ADR‐related hospital admissions.Keywords
This publication has 43 references indexed in Scilit:
- Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymesExpert Opinion on Drug Metabolism & Toxicology, 2010
- Dynamic in Vivo Binding of STAT5 to Growth Hormone-Regulated Genes in Intact Rat Liver. Sex-Specific Binding at Low- But Not High-Affinity STAT5 SitesMolecular Endocrinology, 2009
- Sex Differences in Pharmacokinetics and PharmacodynamicsClinical Pharmacokinetics, 2009
- Hormonal Regulation of Hepatic Drug-Metabolizing Enzyme Activity During AdolescenceClinical Pharmacology & Therapeutics, 2008
- Incidence of fatal adverse drug reactions: a population based studyBritish Journal of Clinical Pharmacology, 2007
- European Medicines Agency policies for clinical trials leave women unprotected: Figure 1Journal of Epidemiology and Community Health, 2006
- Adverse Drug Reaction-Related HospitalisationsDrug Safety, 2006
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ, 2004
- Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studiesBritish Journal of Clinical Pharmacology, 1998
- Female gender as a risk factor for torsades de pointes associated with cardiovascular drugsJAMA, 1993